欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0638/001
药品名称REVAMADEX 100 mg/mL solution for injection
活性成分
    • Sugammadex sodium 100.0 mg/ml
剂型Solution for injection
上市许可持有人Aspen Pharma Trading Limited 3016 Lake Drive Citywest Business Campus Dublin 24 Co. Dublin D24 X586 Ireland
参考成员国 - 产品名称Malta (MT)
Revamadex Solution for Injection 100mg/ml
互认成员国 - 产品名称
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Germany (DE)
      REVAMADEX 100 mg/ml Injektionslösung
    • Denmark (DK)
      Sugammadex Aspen
    • Belgium (BE)
      Sugammadex Aspen 100 mg/ml solution injectable
    • Netherlands (NL)
    • Ireland (IE)
    • France (FR)
许可日期2022/12/20
最近更新日期2023/07/21
药物ATC编码
    • V03AB35 sugammadex
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase